ASH Clinical News May 2015 | Page 39

CLINICAL NEWS When asked whether these childhood ALL survivors could benefit from participating in widely available exercise programs (such as gyms or group classes) as adults, Dr. Ness stressed that “exercise prescription should be tailored to accommodate the specific needs of each survivor so that he or she can be not only safe, but successful, when starting to exercise. All exercise should be tailored to capacity and interests.” While Dr. Ness’ group did not assess the psychosocial well-being of these patients, other data have shown risks for depression, poor sleep, and poor quality of life among childhood ALL survivors. Dr. Ness concurred that these emotional factors can influence levels of physical activity, so they should be taken into consideration when designing a fitness intervention. In the near future, her group intends to conduct further studies about the effects of dietary protein intake on lean Comparison of Mean Body Composition and Energy Balance Among ALL Survivors by CRT Exposure TABLE 2. No CRT (A) CRT (B) Control (C) p values A vs. B p values B vs. C Mean height 163.9 cm 158 cm 164.2 cm p<0.001 p<0.001 Mean weight 71.1 kg p=0.01 p=0.07 FEMALES Mean BMI 26.4 kg/m 81.2 kg 74.9 kg 32.3 kg/m 27.8 kg/m p<0.001 p<0.001 172.9 cm 2 178.9 cm p=0.003 p<0.001 p=0.09 p=0.39 p=0.62 p=0.12 2 2 MALES Mean height 176.1 cm Mean weight 87.7 kg Mean BMI 87.8 kg 28.8 kg/m 2 87.3 kg 28.4 kg/m 2 27.2 kg/m 2 T:7” 4.2 Allergic Reactions REVLIMID is contraindicated in patients who have demonstrated hypersensitivity (e.g., angioedema, Stevens-Johnson syndrome, toxic epidermal necrolysis) to lenalidomide [see Warnings and Precautions (5.8)]. 5.2 REVLIMID REMS™ Program Because of the embryo-fetal risk [see Warnings and Precautions (5.1)], REVLIMID is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS), the REVLIMID REMS™ program (formerly known as the “RevAssist®” program). Required components of the REVLIMID REMS™ program include the following: • Prescribers must be certified with the REVLIMID REMS™ program by enrolling and complying with the REMS requiremen